| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.33B | 110.39B | 111.01B | 107.83B | 105.67B | 90.10B |
| Gross Profit | 16.75B | 14.74B | 17.15B | 17.70B | 14.64B | 13.92B |
| EBITDA | 10.54B | 8.89B | 11.01B | 12.10B | 8.42B | 8.62B |
| Net Income | 1.18B | 2.44B | 1.76B | 3.70B | 3.05B | 1.27B |
Balance Sheet | ||||||
| Total Assets | 116.73B | 119.09B | 122.67B | 129.57B | 123.11B | 122.03B |
| Cash, Cash Equivalents and Short-Term Investments | 3.94B | 4.88B | 9.01B | 10.67B | 8.11B | 14.86B |
| Total Debt | 35.74B | 33.35B | 37.19B | 41.69B | 44.01B | 47.85B |
| Total Liabilities | 61.25B | 59.13B | 66.72B | 73.96B | 71.48B | 73.41B |
| Stockholders Equity | 56.43B | 59.95B | 56.89B | 55.60B | 51.62B | 48.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 26.00M | 4.00B | 5.53B | -3.32B | 4.44B |
| Operating Cash Flow | 0.00 | 4.67B | 10.36B | 13.56B | 2.66B | 8.26B |
| Investing Cash Flow | 0.00 | -4.00B | -6.01B | -7.91B | -5.12B | -3.15B |
| Financing Cash Flow | 0.00 | -4.79B | -6.01B | -3.10B | -4.79B | -5.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥62.63B | 12.82 | ― | 2.67% | 0.65% | 22.48% | |
67 Neutral | ¥158.40B | 12.48 | 3.57% | 1.31% | 0.86% | 158.75% | |
65 Neutral | ¥135.58B | 26.17 | ― | 3.19% | 9.42% | -35.70% | |
64 Neutral | ¥25.90B | 9.46 | ― | 3.72% | -0.56% | 44.99% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥785.71B | 13.87 | 2.55% | 3.51% | 0.67% | 31.73% | |
49 Neutral | ¥159.06B | 19.04 | 1.66% | 1.53% | -1.57% | ― |